Gene · 3398
Papers4,188
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
701 to 720 of 4,188
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Dissecting Immunosuppressive Cell Communication Patterns Reveals JunB Proto-Oncogene (JUNB) Shaping a Non-Inflamed Tumor Microenvironment. | Front Genet | 2022 | 35812726 | PubTator, text mining | PubMed |
| Cytoarchitecture, probability maps and segregation of the human insula. | Neuroimage | 2022 | 35809885 | PubTator, text mining | PubMed |
| Single-cell RNA sequencing reveals localized tumour ablation and intratumoural immunostimulant delivery potentiate T cell mediated tumour killing. | Clin Transl Med | 2022 | 35808806 | PubTator, text mining | PubMed |
| GANAB and N-Glycans Substrates Are Relevant in Human Physiology, Polycystic Pathology and Multiple Sclerosis: A Review. | Int J Mol Sci | 2022 | 35806376 | PubTator, text mining | PubMed |
| Dendritic Cell-Based Immunotherapy in Hot and Cold Tumors. | Int J Mol Sci | 2022 | 35806328 | PubTator, text mining | PubMed |
| State-of-the-Art on Wound Vitality Evaluation: A Systematic Review. | Int J Mol Sci | 2022 | 35805886 | PubTator, text mining | PubMed |
| Regeneration or Repair? The Role of Alveolar Epithelial Cells in the Pathogenesis of Idiopathic Pulmonary Fibrosis (IPF). | Cells | 2022 | 35805179 | PubTator, text mining | PubMed |
| Targeting Wnt/β-Catenin Signaling by TET1/FOXO4 Inhibits Metastatic Spreading and Self-Renewal of Cancer Stem Cells in Gastric Cancer. | Cancers (Basel) | 2022 | 35805009 | PubTator, text mining | PubMed |
| Inherited MUTYH mutations cause elevated somatic mutation rates and distinctive mutational signatures in normal human cells. | Nat Commun | 2022 | 35803914 | PubTator, text mining | PubMed |
| Novel prognostic model predicts overall survival in colon cancer based on RNA splicing regulation gene expression. | Cancer Sci | 2022 | 35792657 | PubTator, text mining | PubMed |
| Structural variants shape driver combinations and outcomes in pediatric high-grade glioma. | Nat Cancer | 2022 | 35788723 | PubTator, text mining | PubMed |
| The NCF1 variant p.R90H aggravates autoimmunity by facilitating the activation of plasmacytoid dendritic cells. | J Clin Invest | 2022 | 35788118 | PubTator, text mining | PubMed |
| Identification of prognostic and immunotherapy-related eRNA ID2-AS1 in bladder cancer. | Medicine (Baltimore) | 2022 | 35776987 | PubTator, text mining | PubMed |
| ID2 and HIF-1α collaborate to protect quiescent hematopoietic stem cells from activation, differentiation, and exhaustion. | J Clin Invest | 2022 | 35775482 | PubTator, text mining | PubMed |
| Emerging Concepts in Innate Lymphoid Cells, Memory, and Reproduction. | Front Immunol | 2022 | 35774779 | PubTator, text mining | PubMed |
| The impact of rare germline variants on human somatic mutation processes. | Nat Commun | 2022 | 35764656 | PubTator, text mining | PubMed |
| Bone morphogenetic protein inhibitors and mitochondria targeting agents synergistically induce apoptosis-inducing factor (AIF) caspase-independent cell death in lung cancer cells. | Cell Commun Signal | 2022 | 35761398 | PubTator, text mining | PubMed |
| Activating STING1-dependent immune signaling in TP53 mutant and wild-type acute myeloid leukemia. | Proc Natl Acad Sci U S A | 2022 | 35759659 | PubTator, text mining | PubMed |
| Tissue-Resident Innate Immune Cell-Based Therapy: A Cornerstone of Immunotherapy Strategies for Cancer Treatment. | Front Cell Dev Biol | 2022 | 35757002 | PubTator, text mining | PubMed |
| Human organ rejuvenation by VEGF-A: Lessons from the skin. | Sci Adv | 2022 | 35749494 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3398/papers?page=36